Donate Today Log In

Reproductive Endocrinology Hero

Hormonal Health · Reproductive Medicine

Advancing Fertility and Hormonal Health Through
Reproductive Endocrinology

Ovarian Reserve · Hormonal Profiling · Fertility Mapping · Cycle Analytics · IVF Optimization · Endocrine Disorders

Hormonal

Balance Restored

Fertility

Centered Care

100%

Precision Protocols

Evidence

Based Outcomes

Department Overview

Re·pro·duc·
tive En·do·
cri·nol·o·gy

/ ˌrēprəˈdəktiv ˌendōkrəˈnäləjē / · noun

noun · precision hormonal medicine

The integration of genomic, hormonal, and metabolic profiling with advanced reproductive diagnostics - moving beyond population-average reference ranges to the molecular and endocrine root causes driving infertility, cycle dysregulation, and hormonal dysfunction in each individual patient.

Origin

From Latin reproducere (to produce again) + Greek endon (within) + krinein (to separate) + -logia (study of). Precision reproductive endocrinology emerged as whole-genome sequencing, anti-Müllerian hormone assays, and single-cell transcriptomics of ovarian and endometrial tissue revealed that clinically similar presentations of infertility and hormonal imbalance harbor molecularly distinct etiologies - requiring individualized diagnostic and therapeutic strategies beyond conventional gonadotropin protocols.

The Reproductive Endocrinology Department at the American Board of Precision Medicine trains clinicians to look beyond standard hormone panels and cycle day 3 labs - integrating ovarian reserve assessment, polygenic fertility risk scoring, endometrial receptivity profiling, and microbiome-reproductive axis analysis into a molecularly complete picture of each patient's reproductive biology and treatment response potential.

From PCOS endotype stratification and thyroid-HPG axis crosstalk to mitochondrial oocyte dysfunction, epigenetic imprinting disorders, and pharmacogenomic optimization of ovarian stimulation protocols, this department equips physicians with the molecular and hormonal fluency to identify the upstream biological drivers of reproductive failure - and to design individualized interventions that address root causes rather than symptoms.

Reproductive health is not simply a function of age and anatomy - it is the downstream expression of a patient's entire hormonal, metabolic, and genomic architecture. At ABOPM, Reproductive Endocrinology provides the precision framework to decode that architecture for every patient, transforming fragmented lab values into a coherent, actionable map of individual reproductive potential.

N=1

Hormonal Profiling

Root

Cause Fertility Care

Full

Cycle Optimization

Reproductive Endocrinology Department · ABOPM

Where Hormonal Precision Transforms
Fertility and Reproductive Health

The Reproductive Endocrinology Department at ABOPM is redefining reproductive care training physicians to move beyond standard hormone panels and population-average protocols, integrating genomic fertility profiling, ovarian reserve assessment, endometrial receptivity analysis, and microbiome-reproductive axis mapping into a molecularly complete picture of each patient's unique reproductive biology.

Genomic Fertility Profiling

Advancing clinical application of polygenic fertility risk scoring, ovarian reserve genomics, carrier screening, PCOS endotype stratification, and pharmacogenomic optimization of ovarian stimulation protocols enabling physicians to build a molecularly precise fertility portrait for every patient and guide individualized treatment from first consultation.

Hormonal & Endometrial Systems

Bridging molecular endocrinology and reproductive outcomes developing board-certified frameworks for thyroid-HPG axis crosstalk, mitochondrial oocyte dysfunction assessment, epigenetic imprinting disorder evaluation, endometrial receptivity profiling, and microbiome-reproductive axis analysis to identify and address the upstream hormonal and molecular drivers of reproductive failure.

Physician Education

Building the next generation of precision reproductive endocrinologists through rigorous board standards, molecular hormonal literacy training, and interdisciplinary collaboration across clinical genomics, reproductive immunology, metabolic medicine, epigenetics, and translational fertility science.

"Reproductive health is not simply a function of age and anatomy - it is the downstream expression of a patient's entire hormonal, metabolic, and genomic architecture. The Reproductive Endocrinology Department at ABOPM trains physicians to decode that architecture for every patient, transforming fragmented lab values into a coherent, actionable map of individual reproductive potential."

American Board of Precision Medicine · Reproductive Endocrinology Department

Become a Member → Support Our Mission → Get Involved →

Reproductive Endocrinology Department · ABOPM

Decoding Each Patient's Reproductive Biology
to Deliver Precision Fertility and Hormonal Care

No two patients fail to conceive for the same molecular reason. Behind every unexplained infertility diagnosis, every PCOS presentation, and every recurrent implantation failure lies a specific biological substrate - polygenic fertility variants, hormonal axis dysregulations, endometrial molecular signatures, and microbiome-reproductive crosstalk patterns that population-based gonadotropin protocols and standard cycle day 3 labs were never designed to resolve. Identifying the molecular architecture of each patient's reproductive biology - and matching intervention to that architecture - is not a specialized aspiration; it is the precision obligation of modern reproductive endocrinology.

Precision reproductive endocrinology equips clinicians to move beyond standard serology and empirical stimulation protocols and into molecularly stratified fertility care applying genomic profiling, endometrial transcriptomics, hormonal axis mapping, and microbiome analysis to identify the upstream biological drivers of reproductive failure and design individualized intervention strategies from the first clinical encounter.

By mastering precision reproductive endocrinology, clinicians gain the power to:

01

Build Each Patient's Genomic Fertility Portrait

Move beyond AMH and FSH to construct a molecularly complete fertility profile applying polygenic fertility risk scoring, carrier screening interpretation, ovarian reserve genomics, and PCOS endotype stratification to identify the specific genetic and molecular architecture driving each patient's reproductive challenges and design targeted interventions from the first consultation rather than after multiple failed cycles.

02

Map Hormonal Axis Dysregulation with Molecular Precision

Apply thyroid-HPG axis crosstalk analysis, adrenal-ovarian interaction profiling, insulin resistance trajectory assessment, and prolactin pathway evaluation to identify the specific hormonal network disruptions driving cycle dysregulation, anovulation, and implantation failure enabling mechanistically targeted hormonal interventions that address root causes rather than suppress symptoms.

03

Profile Endometrial Receptivity and Oocyte Quality

Integrate endometrial receptivity transcriptomic profiling, window of implantation testing, mitochondrial oocyte dysfunction assessment, and epigenetic imprinting disorder evaluation to characterize the molecular environment at the site of implantation identifying patient-specific endometrial and oocyte factors that predict IVF success and guide embryo transfer timing and preparation strategies with molecular precision.

04

Apply PGx-Optimized Stimulation and Microbiome Analysis

Use pharmacogenomic profiling of gonadotropin receptor variants, CYP enzyme polymorphisms, and drug transporter genetics to individualize ovarian stimulation protocols eliminating poor responder and hyper-responder outcomes through genotype-guided dosing, while integrating reproductive microbiome analysis to identify dysbiotic patterns that impair endometrial receptivity and embryo implantation.

05

Lead Precision Reproductive Medicine at Your Institution

Become the molecular reproductive endocrinology authority your institution needs - the physician who builds genomically grounded fertility programs, leads endometrial receptivity and oocyte quality optimization clinics, and creates the institutional infrastructure for precision reproductive care that moves patients from empirical protocol cycling to molecularly individualized strategies that maximize reproductive outcomes from the first intervention.

Why Reproductive Endocrinology Certification Is Non-Negotiable

Every patient has a reproductive biology. The question is, are you equipped to decode it?

Precision-Driven Outcomes

Molecularly stratified reproductive care consistently outperforms empirical protocol cycling delivering measurably better live birth rates, fewer failed cycles, and reduced treatment burden by identifying and addressing the specific molecular drivers of each patient's reproductive failure from the first clinical decision rather than discovering them through costly, time-sensitive trial and error.

Future-Ready Practice

Endometrial transcriptomics, polygenic fertility scoring, mitochondrial oocyte profiling, AI-guided stimulation optimization, and reproductive microbiome analysis are transforming fertility medicine - physicians board-certified in precision reproductive endocrinology will define the next generation of molecularly individualized reproductive care.

Clinical Authority

Board certification in precision reproductive endocrinology marks you as the genomic fertility and molecular hormonal medicine authority - a physician equipped to lead complex infertility programs, precision IVF optimization clinics, and institutional reproductive medicine initiatives grounded in molecular biology rather than empirical protocol application.

Cross-System Impact

Precision reproductive endocrinology principles span infertility, PCOS, recurrent pregnancy loss, endometriosis, premature ovarian insufficiency, and hormonal aging giving you a molecularly grounded framework to address reproductive and hormonal health across the full lifespan and every clinical presentation you encounter.

Active research areas driving precision reproductive endocrinology forward:

01

Genomic Fertility Profiling & Polygenic Risk

Advancing the construction and clinical validation of polygenic fertility risk scores — characterizing the genetic variants in AMH pathway genes, ovarian reserve determinants, FSH receptor polymorphisms, and folliculogenesis regulators that predict ovarian reserve trajectory, stimulation response, and age-related fertility decline, building the evidence base for genotype-guided fertility counseling and proactive reproductive planning that replaces reactive diagnosis with molecular foresight.

02

PCOS Endotype Stratification & Molecular Classification

Developing molecularly coherent PCOS endotype classification frameworks beyond Rotterdam criteria — applying genomic, metabolomic, androgen pathway, and insulin resistance profiling to define biologically distinct PCOS subtypes that predict differential response to ovulation induction, insulin sensitization, GnRH agonist therapy, and lifestyle interventions, enabling treatment selection matched to the specific hormonal and metabolic architecture of each patient's PCOS phenotype.

03

Endometrial Receptivity & Implantation Biology

Advancing the molecular characterization of endometrial receptivity — applying transcriptomic profiling of the window of implantation, single-cell RNA sequencing of endometrial stromal and epithelial cell populations, endometrial microbiome composition analysis, and immune tolerance pathway assessment to identify the patient-specific molecular barriers to implantation that explain recurrent IVF failure and guide precision endometrial preparation and embryo transfer timing strategies.

04

Oocyte Mitochondrial Function & Epigenetic Integrity

Characterizing the mitochondrial and epigenetic determinants of oocyte quality — advancing mtDNA copy number analysis, mitochondrial membrane potential assessment, reactive oxygen species quantification, and oocyte epigenetic imprinting evaluation methods that identify the molecular signatures of oocyte competence and predict embryo developmental potential, enabling precision embryo selection strategies and targeted mitochondrial support interventions grounded in each patient's specific oocyte biology.

05

Pharmacogenomics of Ovarian Stimulation

Building the pharmacogenomic evidence base for individualized ovarian stimulation protocol design — characterizing FSH receptor (FSHR), LH receptor (LHCGR), AMH receptor, and CYP19A1 aromatase variants that predict poor responder and hyper-responder phenotypes, gonadotropin dose requirements, and ovarian hyperstimulation syndrome risk, enabling PGx-guided stimulation protocols that optimize oocyte yield while eliminating genotype-predictable treatment complications before they occur.

Reproductive Endocrinology Research · ABOPM

Decoding the Molecular Biology of Fertility and Hormonal Health

The precision reproductive medicine revolution is not a future event — it is rewriting how fertility is assessed and treated today. Genomic fertility profiling, PCOS endotype stratification, endometrial transcriptomics, oocyte mitochondrial assessment, and pharmacogenomic stimulation optimization are actively transforming how every fertility challenge and hormonal dysregulation is diagnosed, stratified, and therapeutically addressed at the molecular and individual patient level.

The ABOPM Reproductive Endocrinology Department positions clinicians at the center of this transformation — equipping them with the molecular hormonal literacy, genomic fertility frameworks, and board-certified credentials to lead precision reproductive endocrinology programs across every fertility presentation and hormonal health domain.

1 in 6

Couples globally affected by infertility

40%

Of infertility cases remain unexplained by standard workup

PGx

Guided stimulation replacing empirical gonadotropin dosing

Explore Blog Topics → Read clinical insights, case studies & reproductive endocrinology updates on our blog

Precision Reproductive Endocrinology Department · ABOPM

Meet Our Leadership

Director of Precision Reproductive Endocrinology

Director

Precision Reproductive Endocrinology

Director of Precision Reproductive Endocrinology Founder · Montgomery Fertility Center

Yemi Famuyiwa, MD

Board-Certified Reproductive Endocrinologist · NIH Fellowship · Assoc. Clinical Professor · George Washington University

"Blending precision medicine, systems biology, and exposomic analysis with fertility care — bridging clinical insight and empowering education to help every patient navigate their unique path to reproductive health."

Dr. Famuyiwa is a board-certified Reproductive Endocrinologist and the Founder and Medical Director of Montgomery Fertility Center in Rockville, Maryland. She completed her fellowship in Reproductive Endocrinology and Infertility at the National Institutes of Health (NIH) and serves as an Associate Clinical Professor at George Washington University School of Medicine.

She is the author of the forthcoming book The Quest for Fertility and the host of the Fertile Talks podcast, where she bridges clinical insights with empowering fertility education for patients and providers alike. A frequent media guest and thought leader, she is currently developing The Fertility Blueprint Lab — a concierge precision medicine program applying systems biology and exposomic analysis to reproductive health.

NIH

Fellowship Trained

GWU

Associate Clinical Professor

Prec.

Fertility Blueprint Lab

Connect on LinkedIn

Faculty Members

Our faculty roster is growing — announcements coming soon.

Coming Soon

Faculty position open

Coming Soon

Faculty position open

Coming Soon

Faculty position open

Coming Soon

Faculty position open

Think you're the right fit for a faculty position?

Get Involved →

Genomics Department · ABOPM

Shaping the Future
of Precision Medicine

As precision medicine continues to evolve, genomics will play an increasingly central role in redefining how disease is understood, predicted, and treated at the molecular level.

The Genomics Department at ABOPM remains committed to advancing this field through scientific leadership, clinical innovation, and collaborative discovery. Together with our global community of physicians and researchers, we are helping shape the future of next-generation healthcare.

Explore Certification → Get Involved

Featured Insights

Insights Shaping
Precision Medicine

Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.

Multi-Omics Clinical Innovation Precision Prevention Physician Leadership

Liquid Biopsy and Early Cancer Detection: Promise and Limitations

Liquid biopsy is transforming cancer detection through minimally invasive genomic testing, offering new opportunities for earlier diagnosis and monitoring. ...more

Precision Oncology

June 05, 2026•9 min read

Polygenic Risk Scores and the Genomic Data Gap: Promise, Limitations, and Equity in Precision Medicine

Polygenic risk scores may transform disease prediction, but gaps in genomic diversity continue to limit equity, accuracy, and access in precision medicine across global populations. ...more

Population Precision

May 26, 2026•9 min read

Artificial Intelligence in Precision Medicine

Artificial intelligence is reshaping precision medicine by improving diagnostics, predicting treatment response, and enabling more personalized, data-driven healthcare strategies. ...more

On the Frontier

May 20, 2026•9 min read